Literature DB >> 19563260

Effect of the alphaGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model.

Kerry A Daly1, Ann M Stewart-Akers, Hidetaka Hara, Mohamed Ezzelarab, Cassandra Long, Kevin Cordero, Scott A Johnson, David Ayares, David K C Cooper, Stephen F Badylak.   

Abstract

The Galalpha1,3Galbeta1,4GlcNAc-R (Gal) epitope is a major factor in the hyperacute rejection of pig organ transplants in primates. Biologic scaffold materials used for tissue reconstruction and composed of xenogeneic extracellular matrix (ECM) may contain the Gal epitope. However, the effect of this epitope upon the host response is controversial. The present study investigated the effect of the Gal epitope upon the host response to a porcine-derived ECM in an African Green monkey (Cholrocaebus aethiops) abdominal wall resection model. Histologic methods, serology, complement-dependent cytotoxicity, and gene expression profiling were used to evaluate the host response to allogeneic and both wild-type and Gal-deficient xenogeneic scaffold materials. Although expression of the Gal epitope induced an increase in serum anti-Gal antibodies in recipients, no other differences were noted in the host response between test articles. All ECM scaffolds were well tolerated and showed constructive remodeling during the study period. Recipients of all test articles showed no histologic or humoral evidence of sensitization when a second scaffold was implanted 45 days after the original surgery. The findings of the present study show that the presence of the Gal epitope within a porcine-derived ECM scaffold material elicits a serum antibody response, but no adverse effect upon tissue remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563260     DOI: 10.1089/ten.TEA.2009.0089

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  40 in total

1.  Right ventricular outflow tract repair with a cardiac biologic scaffold.

Authors:  John M Wainwright; Ryotaro Hashizume; Kazuro L Fujimoto; Nathaniel T Remlinger; Colin Pesyna; William R Wagner; Kimimasa Tobita; Thomas W Gilbert; Stephen F Badylak
Journal:  Cells Tissues Organs       Date:  2011-10-24       Impact factor: 2.481

2.  Biologic scaffold composed of skeletal muscle extracellular matrix.

Authors:  Matthew T Wolf; Kerry A Daly; Janet E Reing; Stephen F Badylak
Journal:  Biomaterials       Date:  2012-01-20       Impact factor: 12.479

3.  Comparison of three methods for the derivation of a biologic scaffold composed of adipose tissue extracellular matrix.

Authors:  Bryan N Brown; John M Freund; Li Han; J Peter Rubin; Janet E Reing; Eric M Jeffries; Mathew T Wolf; Stephen Tottey; Christopher A Barnes; Buddy D Ratner; Stephen F Badylak
Journal:  Tissue Eng Part C Methods       Date:  2011-02-05       Impact factor: 3.056

4.  The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds.

Authors:  Janet E Reing; Bryan N Brown; Kerry A Daly; John M Freund; Thomas W Gilbert; Susan X Hsiong; Alexander Huber; Karen E Kullas; Stephen Tottey; Matthew T Wolf; Stephen F Badylak
Journal:  Biomaterials       Date:  2010-08-21       Impact factor: 12.479

Review 5.  The current state of scaffolds for musculoskeletal regenerative applications.

Authors:  Benjamin D Smith; Daniel A Grande
Journal:  Nat Rev Rheumatol       Date:  2015-03-17       Impact factor: 20.543

6.  Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering.

Authors:  Mary E Tedder; Agneta Simionescu; Joseph Chen; Jun Liao; Dan T Simionescu
Journal:  Tissue Eng Part A       Date:  2010-09-06       Impact factor: 3.845

Review 7.  Perspectives on whole-organ assembly: moving toward transplantation on demand.

Authors:  Alejandro Soto-Gutierrez; Jason A Wertheim; Harald C Ott; Thomas W Gilbert
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

8.  Graft-specific immune tolerance is determined by residual antigenicity of xenogeneic extracellular matrix scaffolds.

Authors:  Ailsa J Dalgliesh; Mojtaba Parvizi; Manuela Lopera-Higuita; Jeny Shklover; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2018-08-18       Impact factor: 8.947

9.  Improving functional re-endothelialization of acellular liver scaffold using REDV cell-binding domain.

Authors:  Julie Devalliere; Yibin Chen; Kevin Dooley; Martin L Yarmush; Basak E Uygun
Journal:  Acta Biomater       Date:  2018-07-31       Impact factor: 8.947

10.  Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.

Authors:  Sonya B Seif-Naraghi; Jennifer M Singelyn; Michael A Salvatore; Kent G Osborn; Jean J Wang; Unatti Sampat; Oi Ling Kwan; G Monet Strachan; Jonathan Wong; Pamela J Schup-Magoffin; Rebecca L Braden; Kendra Bartels; Jessica A DeQuach; Mark Preul; Adam M Kinsey; Anthony N DeMaria; Nabil Dib; Karen L Christman
Journal:  Sci Transl Med       Date:  2013-02-20       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.